| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.33 | 0.02 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |